Drug-induced pemphigus

Clinics in Dermatology

Volumn 29, Issue 4, 2011, Pages 455-457

  Brenner, Sarah ^a   Goldberg, Ilan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; GAMMA INTERFERON; OINTMENT BASE; PENICILLAMINE; PHENOL DERIVATIVE; THIOL DERIVATIVE;

ARTICLE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG EFFECT; DRUG EXPOSURE; DRUG INDUCED DISEASE; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IN VITRO STUDY; INTERFERON GAMMA RELEASE ASSAY; LONG TERM EXPOSURE; PEMPHIGUS; PRIORITY JOURNAL;

DERMATITIS, CONTACT; HUMANS; INTERFERON-GAMMA; LYMPHOCYTES; PEMPHIGUS; PHENOLS; SULFHYDRYL COMPOUNDS;

EID: 79958807221     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.01.016     Document Type: Article

References (30)

1. Brenner S., Mashiah J., Tamir E., et al. PEMPHIGUS: An acronym for a disease with multiple etiologies. Skinmed 2003, 2:163-167.
2. Marsden R.A., Vanhegan R.I., Walshe M., et al. Pemphigus foliaceus induced by penicillamine. Br Med J 1976, 4:1423-1424.
3. Goldberg I., Ingber A., Brenner S. Pemphigus vulgaris triggered by rifampin and emotional stress. Skinmed 2004, 3:294.
4. Brenner S., Bialy-Golan A., Ruocco V. Drug-induced pemphigus. Clin Dermatol 1998, 16:393-397.
5. Brenner S., Ruocco V. D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1. J Am Acad Dermatol 1998, 39:137-138.
6. Brenner S., Bialy-Golan A., Crost N. Dipyrone in the induction of pemphigus. J Am Acad Dermatol 1997, 36:488-490.
7. Matz H., Bialy-Golan A., Brenner S. Diclofenac: a new trigger of pemphigus vulgaris?. Dermatology 1997, 195:48-49.
8. Brenner S., Ruocco V., Bialy-Golan A., et al. Pemphigus and pemphigoid-like effects of nifedipine on in vitro cultured normal human skin explants. Int J Dermatol 1999, 38:36-40.
9. Goldberg I., Kashman Y., Brenner S. The induction of pemphigus by phenol drugs. Int J Dermatol 1999, 38:888-892.
10. Kaplan R.P., Potter T.S., Fox J.N. Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors. J Am Acad Dermatol 1992, 26:364-366.
11. Paterson A.J., Lamey P.J., Lewis M.A., et al. Pemphigus vulgaris precipitated by glibenclamide therapy. J Oral Pathol Med 1993, 22:92-95.
12. Goldberg I., Sasson A., Gat A., et al. Pemphigus vulgaris triggered by glibenclamide and cilazapril. Acta Dermatovenerol Croat 2005, 13:153-155.
13. Orion E., Gazit E., Brenner S. Pemphigus vulgaris possibly triggered by cilazapril. Acta Derm Venereol 2000, 80:220.
14. Buzon E., Perez-Bernal A.M., de la Pena F., et al. Pemphigus foliaceus associated with cilazapril. Acta Derm Venereol 1998, 78:227.
15. Brenner S., Hodak E., Dascalu D., et al. A possible case of drug-induced familial pemphigus. Acta Derm Venereol 1990, 70:357-358.
16. Fiore P.M., Jacobs I.H., Goldberg D.B. Drug-induced pemphigoid. A spectrum of diseases. Arch Ophthalmol 1987, 105:1660-1663.
17. Perez Espana L., Hervella Garces M., Belen Piteiro A., et al. [Haloperidol induced pemphigus foliaceus.]. Med Clin (Barc) 2003, 120:117-118. [Spanish].
18. Korang K., Ghohestani R., Krieg T., et al. Exacerbation of pemphigus foliaceus after tetanus vaccination accompanied by synthesis of auto-antibodies against paraneoplastic pemphigus antigens. Acta Derm Venereol 2002, 82:482-483.
19. Mignogna M.D., Lo Muzio L., Ruocco E. Pemphigus induction by influenza vaccination. Int J Dermatol 2000, 39:800.
20. Cozzani E., Cacciapuoti M., Parodi A., et al. Pemphigus following tetanus and diphtheria vaccination. Br J Dermatol 2002, 147:188-189.
21. Brenner S., Wolf R., Ruocco V. Contact pemphigus: a subgroup of induced pemphigus. Int J Dermatol 1994, 33:843-845.
22. Lin R., Ladd D.J., Powell D.J., et al. Localized pemphigus foliaceus induced by topical imiquimod treatment. Arch Dermatol 2004, 140:889-890.
23. Campagne G., Roca M., Martinez A. Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect. Eur J Obstet Gynecol Reprod Biol 2003, 109:224-227.
24. Mashiah J., Brenner S. Possible mechanisms in the induction of pemphigus foliaceus by topical imiquimod treatment. Arch Dermatol 2005, 141:908-909.
25. Ruocco V., De Angelis E., Lombardi M.L. Drug-induced pemphigus. II. Pathomechanisms and experimental investigations. Clin Dermatol 1993, 11:507-513.
26. Newby C.S., Barr R.M., Greaves M.W., et al. Cytokine release and cytotoxicity in human keratinocytes and fibroblasts induce d by phenols and sodium dodecyl sulfate. J Invest Dermatol 2000, 115:292-298.
27. Feliciani C., Toto P., Amerio P., et al. In vitro and in vivo expression of interleukin-1α and tumor necrosis factor-α mRNA in pemphigus vulgaris: interleukin-1α and tumor necrosis factor-α are involved in acantholysis. J Invest Dermatol 2000, 114:71-77.
28. Goldberg I., Gilburd B., Shovman O., et al. Clinical and laboratory assays in the diagnosis of cutaneous adverse drug reactions. Isr Med Assoc J 2004, 6:50-51.
29. Halevy S., Cohen A.D., Grossman N. In vitro interferon-gamma release-a laboratory diagnosis of cutaneous adverse drug reactions. Harefuah 2001, 140:121-124. [Hebrew].
30. Halevy S., Cohen A.D., Grossman N. Clinical implications of in vitro drug-induced interferon gamma release from peripheral blood lymphocytes in cutaneous adverse drug reactions. J Am Acad Dermatol 2005, 52:254-261.